First Time Loading...

Adaptimmune Therapeutics PLC
NASDAQ:ADAP

Watchlist Manager
Adaptimmune Therapeutics PLC Logo
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Watchlist
Price: 1.04 USD -0.95% Market Closed
Updated: May 29, 2024

Adaptimmune Therapeutics PLC
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adaptimmune Therapeutics PLC
Common Shares Outstanding Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Common Shares Outstanding
$1.5B
CAGR 3-Years
18%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Common Shares Outstanding
$98.8m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Common Shares Outstanding
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Common Shares Outstanding
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Common Shares Outstanding
£49.7m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Common Shares Outstanding
£66m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Adaptimmune Therapeutics PLC's Common Shares Outstanding?
Common Shares Outstanding
1.5B USD

Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Common Shares Outstanding amounts to 1.5B USD.

What is Adaptimmune Therapeutics PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
20%

Over the last year, the Common Shares Outstanding growth was 54%. The average annual Common Shares Outstanding growth rates for Adaptimmune Therapeutics PLC have been 18% over the past three years , 20% over the past five years .